88 related articles for article (PubMed ID: 21448524)
1. Left ventricular hypertrophy in patients with chronic kidney disease under conservative treatment.
Bregman R; Lemos C; Pecoits Filho R; Abensur H; Draibe S; Bastos MG; Canziani ME
J Bras Nefrol; 2010 Mar; 32(1):83-8. PubMed ID: 21448524
[TBL] [Abstract][Full Text] [Related]
2. [Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney].
Tomilina NA; Storozhakov GI; Gendlin GE; Badaeva SV; Zhidkova DA; Kim IG; Borisovskaia SV; Loss KE; Fedorova ND
Ter Arkh; 2007; 79(6):34-40. PubMed ID: 17684964
[TBL] [Abstract][Full Text] [Related]
3. Left ventricular hypertrophy versus chronic kidney disease as predictors of cardiovascular events in hypertension: a Greek 6-year-follow-up study.
Tsioufis C; Vezali E; Tsiachris D; Dimitriadis K; Taxiarchou E; Chatzis D; Thomopoulos C; Syrseloudis D; Stefanadi E; Mihas C; Katsi V; Papademetriou V; Stefanadis C
J Hypertens; 2009 Apr; 27(4):744-52. PubMed ID: 19516174
[TBL] [Abstract][Full Text] [Related]
4. [Left ventricular hypertrophy in predialysis chronic kidney disease: impact of cardiomuscular stress markers].
Kimura T; Iio K; Obi Y; Hayashi T
Nihon Jinzo Gakkai Shi; 2007; 49(8):1007-13. PubMed ID: 18186229
[TBL] [Abstract][Full Text] [Related]
5. Correlation of anemia, secondary hyperparathyroidism with left ventricular hypertrophy in Chronic Kidney Disease patients.
Datta S; Abraham G; Mathew M; Somasundaram H; Muralidharan TR; Moorthy A; Sathyasekaran ; Leslie N
J Assoc Physicians India; 2006 Sep; 54():699-703. PubMed ID: 17212016
[TBL] [Abstract][Full Text] [Related]
6. The long-term behavior and predictors of left ventricular hypertrophy in hemodialysis patients.
Kutlay S; Dincer I; Sengül S; Nergizoglu G; Duman N; Ertürk S
Am J Kidney Dis; 2006 Mar; 47(3):485-92. PubMed ID: 16490628
[TBL] [Abstract][Full Text] [Related]
7. Electrocardiographic abnormalities among dialysis naïve chronic kidney disease patients in Ilorin Nigeria.
Chijioke A; Makusidi AM; Kolo PM
Ann Afr Med; 2012; 11(1):21-6. PubMed ID: 22199043
[TBL] [Abstract][Full Text] [Related]
8. Circulating soluble receptor for advanced glycation end product (sRAGE) and left ventricular hypertrophy in patients with chronic kidney disease (CKD).
Leonardis D; Basta G; Mallamaci F; Cutrupi S; Pizzini P; Tripepi R; Tripepi G; De Caterina R; Zoccali C
Nutr Metab Cardiovasc Dis; 2012 Sep; 22(9):748-55. PubMed ID: 21470837
[TBL] [Abstract][Full Text] [Related]
9. Impact of volume status on blood pressure and left ventricle structure in patients undergoing chronic hemodialysis.
Koc Y; Unsal A; Kayabasi H; Oztekin E; Sakaci T; Ahbap E; Yilmaz M; Akgun AO
Ren Fail; 2011; 33(4):377-81. PubMed ID: 21529265
[TBL] [Abstract][Full Text] [Related]
10. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A
J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
[TBL] [Abstract][Full Text] [Related]
11. Left ventricular hypertrophy in hypertensive type 2 diabetic patients according to renal function.
Blanchet Deverly A; Kangambega P; Hue K; Donnet JP; Merault H; Foucan L
Diabetes Metab; 2009 Sep; 35(4):280-6. PubMed ID: 19423378
[TBL] [Abstract][Full Text] [Related]
12. [Left ventricular hypertrophy among hypertensive patients with diminished glomerular filtration rate].
Grabysa R; Cholewa M
Pol Merkur Lekarski; 2008 Oct; 25(148):309-14. PubMed ID: 19145927
[TBL] [Abstract][Full Text] [Related]
13. [Risk factors for myocardial remodeling at stage II-IV of chronic kidney disease].
Rudenko TE; Kutyrina IM; Shvetsov MIu
Ter Arkh; 2012; 84(6):21-6. PubMed ID: 22997913
[TBL] [Abstract][Full Text] [Related]
14. Persistence of left ventricular hypertrophy is a stronger indicator of cardiovascular events than baseline left ventricular mass or systolic performance: 10 years of follow-up.
Muiesan ML; Salvetti M; Rizzoni D; Monteduro C; Castellano M; Agabiti-Rosei E
J Hypertens Suppl; 1996 Dec; 14(5):S43-9. PubMed ID: 9120684
[TBL] [Abstract][Full Text] [Related]
15. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients.
Khan IA; Fink J; Nass C; Chen H; Christenson R; deFilippi CR
Am J Cardiol; 2006 May; 97(10):1530-4. PubMed ID: 16679099
[TBL] [Abstract][Full Text] [Related]
16. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients.
Wang AY; Wang M; Woo J; Lam CW; Lui SF; Li PK; Sanderson JE
J Am Soc Nephrol; 2004 Aug; 15(8):2186-94. PubMed ID: 15284304
[TBL] [Abstract][Full Text] [Related]
17. [Left ventricular hypertrophy in patient on dialysis].
Lovcić V; Sebetić D; Klobucić M; Kusec V
Acta Med Croatica; 2003; 57(1):61-4. PubMed ID: 12876866
[TBL] [Abstract][Full Text] [Related]
18. Left ventricular geometry and cardiovascular mortality based on haemodialysis patient autopsy analyses.
Mimura I; Nishi H; Mise N; Mori M; Sugimoto T
Nephrology (Carlton); 2010 Aug; 15(5):549-54. PubMed ID: 20649875
[TBL] [Abstract][Full Text] [Related]
19. Association of white blood cell count with left ventricular hypertrophy and ejection fraction in stable hemodialysis patients.
Nasri H
Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):31-6. PubMed ID: 17237888
[TBL] [Abstract][Full Text] [Related]
20. [Cardiovascular disease in Chinese chronic renal insufficiency patients-epidemiology survey].
Hou FF; Ma ZG; Mei CL; Rong S; Huang SM; Liu XR; Yuan WJ; Guo YS; Wang L; He Q; Wang XL; Sang XH; Li XL
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):458-63. PubMed ID: 15854551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
